Vimarsana
Biggest News Aggregation in the World

Pharma Intelligence Center News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pharma Intelligence Center. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pharma Intelligence Center Today - Breaking & Trending Today

Climate Change Fuels Surge in Multiple Sclerosis Cases - Vimarsana News

Climate Change Fuels Surge in Multiple Sclerosis Cases

Climate change-induced exacerbations will increase the number of multiple sclerosis cases.

Radiomics research identifies new imaging markers in laryngeal cancer - Vimarsana News

Radiomics research identifies new imaging markers in laryngeal cancer

Amar Rajgor and his team at Newcastle University are now planning a 250-patient study to improve laryngeal cancer outcomes.

Source: yahoo.com
Pioneer Institute study finds IRA discourages non-opioid drug innovation - Vimarsana News

Pioneer Institute study finds IRA discourages non-opioid drug innovation

The IRA adds another hurdle to an already challenging research landscape, according to a study from the Pioneer Institute.

Source: yahoo.com
Top 20 biopharma kick off 9.6% market cap surge in Q1 2024 amid Medicare price talks - Vimarsana News

Top 20 biopharma kick off 9.6% market cap surge in Q1 2024 amid Medicare price talks

Some companies, however, reported a market capitalisation decline, including Gilead Sciences and Roche.

Source: yahoo.com
Resmetirom For MASH: Approved by US FDA, Increase in Partnerships - Vimarsana News

Resmetirom For MASH: Approved by US FDA, Increase in Partnerships

The increasing trend in strategic partnerships between innovator companies, and the US FDA approval for Rezdiffra has led to a boost in the development of medications for MASH.